The approval of perpetual futures contracts in the US may expose traders to unforeseen tax and regulatory uncertainty, according to CME Group Chairman and CEO Terry Duffy. This uncertainty stems from the ambiguity surrounding the classification of perpetual futures as either swaps or futures, which could significantly impact their tax treatment.
Duffy argues that perpetual futures should be considered swaps due to the periodic funding payments exchanged between long and short positions, which aligns with the statutory definition of a swap under US law. However, the Commodity Futures Trading Commission (CFTC) currently categorizes them as futures.
The discrepancy in classification could lead to institutional traders receiving a blended tax treatment under Section 1256 of the US tax code, which may not be applicable if perpetual contracts are deemed swaps. The issue remains unresolved, with the IRS yet to provide guidance on the tax treatment of perpetual futures, leaving market participants uncertain about how to report these contracts. Legal experts emphasize that the challenge lies in determining the substance and function of perpetual futures, which could be deemed either swaps or futures, depending on the interpretation of the statutory language.
The outcome of the ongoing court battle between CME and the CFTC will likely play a significant role in determining the tax treatment and regulatory status of perpetual futures in the US.